Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.
4 reports, 3 independent
Updated Sep 11
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BofA raised its target price for Elevance Health while NPS reduced its stock stake.1 source
Analyst reports raise price targets for Elevance Health.1 source
Keep exploring
The entities involved
-
Bank of America
American multinational banking and financial services corporation
-
Elevance Health, Inc.
American healthcare company
Nothing else this week.
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Analyst reports are affecting stock price targets for Louisiana-Pacific and Bank of America.
- Analyst ratings influenced stock price targets for Infinity Natural Resources Inc. involving Raymond James Financial, Royal Bank of Canada, and Citigroup.
- Analyst rating targets are affecting stock prices, and required reports regarding ownership stakes are being filed with the SEC for Bank of America and KBR, Inc.
- Analyst firms provided ratings and price targets for Merit Medical Systems on August 28, 2026, involving Raymond James Financial and Bank of America Corp.
- Analysts from Raymond James Financial, Desjardins, and Royal Bank of Canada increased price targets and ratings for Exchange Income Co.